Test Catalog

Test ID: IDH12    
Isocitrate Dehydrogenase 1 and 2 (IDH1/IDH2) Mutation Analysis, Tumor

Useful For Suggests clinical disorders or settings where the test may be helpful

Supporting a morphological diagnosis of a diffuse glioma


Assisting in central nervous system tumor classification


Stratifying prognosis of diffuse gliomas


Supporting the differential diagnosis of chondroid bone tumors


Stratifying prognosis of acute myeloid leukemia

Additional Tests Lists tests that are always performed, at an additional charge, with the initial tests.

Test IDReporting NameAvailable SeparatelyAlways Performed
SLIRVSlide Review in MGNo, (Bill Only)Yes

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR)-Based Next-Generation Sequencing

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

IDH1/IDH2 Mutation Analysis, Tumor

Aliases Lists additional common names for a test, as an aid in searching

Isocitrate Dehydrogenase 1
Isocitrate Dehydrogenase 2
Next Gen Sequencing Test
Diffuse glioma
Acute myeloid leukemia